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Normal rat spleens contain suppressor cells which can inhibit proliferative and cyto- 
toxic responses of lymphocytes to alloantigens ijz vitro. The suppressor cells are ad- 
herent, phagocytic, resistant to treatment with ATS and C, radioresistant, resistant to 
treatment with mitomycin C, apparently absent from the thymus, and found in very 
high concentrations in peritoneal exudates. These characteristics indicate that the sup- 
pressor cell is a macrophages and not a T cell. When suppressor cells were removed 
from spleen cell suspensions, strong ilz vitro proliferative and cytotoxic responses to 
alloantigens could consistently be observed. 
INTRODUCTION 
In viho lymphoproliferative responses have been difficult to demonstrate in the 
spleens of rats (1). Consistent demonstration of in vitro generation of high cyto- 
toxic reactivity to alloantigens which is dependent on a proliferative response (Z-4) 
required the use of lymph node cells as responders (5). In contrast, in mice, the 
spleen is routinely used as a source of effector cells for MLC-CML5 reactions and 
thus the poor reactivity in the rat spleens has not been easily explained. Two main 
possibilities need to be considered: either the rat, unlike the mouse, does not have 
alloreactive cells in the spleen, suggesting a different functional T-cell distribution 
in closely related species, or the rat spleen contains suppressor cells which can 
inhibit proliferative responses. A recent study of CML in rats has shown that their 
spleens do have cells capable of a proliferative and cytotoxic response to allo- 
antigen, but these responses were demonstrable only after depletion of an adherent 
4 Address reprint requests to Dr. J. Ronald Oehler, Laboratory of Itnmunodiagnosis, National 
Cancer Institute, Building 8, Room 112, Bethesda, Maryland 20014. 
s Abbreviations used in this paper: MLC, mixed lymphocyte culture ; CML, cell-mediated 
lympholysis (ila z&o generation of a cytotoxic response to alloantigen) ; GIA, growth inhibi- 
tion assay; MLTI, mixed lymphocyte tumor interactions ; ATS and C, anti-T cell serum and 
complement ; BSS, Hanks’ balanced salt solution ; PEC, peritoneal exudate cells; W/Fu, 
Wistar Furth; BN, Brown Norway; Z-ME, Z-mercaptoethanol ; FBS, fetal bovine serum ; 
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cell population from the responding cells prior to culture (6). The adherent cell 
population, however, was not characterized. Folch and Waksman (7) have pre- 
sented data which they interpreted as demonstrating an adherent T-suppressor cell 
which can strongly inhibit MLC in rat spleens (7). From that work, it would 
appear that an adherent T-suppressor cell was responsible for the inability of 
unfractionated rat spleen cells to respond in MLC or to generate (XL. 
Our laboratory has done extensive testing to suppressor cell activity in both 
tumor and non-tumor systems (%12) and has found adherent suppressor cells with 
the characteristics of macrophages and not T cells. Recently, normal rat spleens, 
unlike normal mouse spleens, were found to have activity in the growth inhibition 
assay, which has been shown to measure cytostatic macrophage activity ( 13, 14). In 
addition, we found that cells active in the growth inhibition assay were also active 
in suppression of the in vitro secondary proliferative response to tumor-associated 
antigens (MLTI) (13). Tl lis appeared to be in contrast to the findings of Folch 
and Waksman, but since our findings were in a tumor system involving a secondary 
response and they had studied a primary response to alloantigen, it was possible 
the findings were not comparable. In order to compare our findings directly, we 
have developed an MLC-CML system in rats and have characterized the adherent 
suppressor cells in the normal rat spleen. Our data indicate that the suppressor 
cells in normal rat spleens which inhibit both MLC and CML are macrophages 
and not T cells. Possible reasons for these disparate findings are discussed. 
MATERIALS AND METHODS 
Aninmls 
Eight- to lo-week-old male W/Fu (Ag-B2) rats usually served as donors for 
responding cells. Ex-breeder male and female BN (Ag-B3) rats usually served 
as donors of stimulating cells. All rats were obtained from Microbiological Asso- 
ciates, Inc., Walkersville, Md. 
Preparation of Lywtphoid Cells 
Spleen, lymph node and thymus cell suspensions were prepared as previously 
described (15). Peripheral blood lymphocytes (PBL) were obtained by cardiac 
puncture. Ten milliliters of heparinized blood were diluted with 10 ml of BSS 
and carefully layered over 10 ml of Ficoll Hypaque (LSM, Litton Bionetics, 
Rockville, Md.) at 22°C. The gradient was then centrifuged at 250g at 22” for 30 
min after which the cells layered at the interface of the Ficoll and B,SS were 
carefully collected, washed and resuspended in complete medium (see below). 
This procedure resulted in a lymphoid population free of granulocytes and consist- 
ing of small lymphocytes and monocytes. Peritoneal exudate cells (PEC) were 
collected from the peritoneal cavity 4 days after injection of 20 ml of light mineral 
oil i.p, Latex particle ingestion techniques consistently showed that 45-55 percent 
of the cells obtained were phagocytic; the remainder appeared under light micro- 
scopy to be small lymphocytes. 
Cell Sepamtion Procedures 
The medium used for all experiments and cell separation procedures was as 
follows: RPM1 medium 1640 (Grand Island Biological Co., Grand Island, N. Y.) 
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containing 25 X 1p3 M HEPES solution (Microbiological Associates, Inc., I+ 
thesda, Md.), 5 X 10e5 M 2-mercaptoethanol ( Schwarz-Mann Division, Becton, 
Dickinson & Co., Orangeburg, N. Y.), 100 units of penicillin per ml, 100 pg of 
streptomycin per ml and 60 pg/ml of gentamicin, 2 mM of glutamine and 10yO 
FBS (all reagents from Grand Island Biological Co.). This will be referred to as 
complete medium. 
Carbonyl iron and magnet. Spleen cells (1 x 108) in 5 ml of medium were 
combined with 200 mg of carbonyl iron powder (GAF Corp., New York, N.Y.) 
and incubated for 1 hr at 37°C in a shaking water bath. Following the incubation 
period, the cell suspension was diluted to 10 ml and serially poured from test tube 
to test tube using a strong magnet to retain cells having phagocytized the iron 
powder at each step. A series of G8 test tubes was used. This procedure resulted 
in a decrease from E&10$% to 1-2s in the proportion of normal spleen cells which 
could ingest latex particles. 
Passage of spleen cells through a ragon colunm. Thirty-five milliliter syringes 
were disassembled, and the barrel was filled with three rayon cotton balls (Parke 
Davis Co., Detroit, Mich.). The assembly was then autoclaved and prepared for 
use as follows: A sterile stopcock was placed on the tip of the syringe and SO ml 
of BSS were rapidly passed through the column. Then 5-8 x 10” spleen cells 
in media were placed on the column and incubated at 37°C in a 5% CO, humid 
atmosphere. After 20 min incubation, the nonadherent cells were eluted with 50 ml 
of warm (37°C) BSS, centrifuged at 250~ for 10 min, and resuspended in com- 
plete medium. Twenty to 30% of the cells were recovered by this procedure. Latex 
particle ingesting cells decreased from S-10$ of the normal spleen population to 
1-2s. This procedure had virtually no effect on the percentage of cells bearing 
surface immunoglobulin (40-5070 of normal spleen population as measured by 
membrane surface immunofluorescence with fluorescein-conjugated goat anti-rat 
immunoglobulin [Lot #4020201, prepared for KC1 by Huntington Research 
Center, Brooklandville, Md.1) The levels of cell-mediated cytotoxicity of immune 
W/Fu spleen cells against (CSSNT) D, a syngeneic Gross virus-induced lymphoma, 
which is T-cell dependent ( 16, 17)) were either unchanged or increased after column 
passage. 
Removal of T Cells 
A burro anti-rat thymocyte antiserum (ATS) was used to specifically remove 
T cells. The methods for producing and absorbing this antiserum have been 
described (16). One-tenth milliliter of this antiserum (diluted 1 : 5) and 0.1 ml 
of undiluted guinea pig serum as a source of complement were added to 0.1 ml of 
1 X lo7 spleen cells, and the mixture was incubated at 37°C for 1 hr. The cells 
were then washed twice with 50 ml of BSS and resuspended in complete medium 
as previously reported (16). This procedure consistently and completely abrogated 
the proliferative response of the spleen cells to PHA and the cytotoxicity of immune 
lymphocytes against (C58NT) D. The number of antibody-producing spleen cells 
from rats immunized against sheep red blood cells was not decreased. In addition, 
macrophages shown to be active in the GIA were not decreased (13). 
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Assays of Functional Activity 
Mixed lymphocyte culture (MLC) was done as follows : 1 X lo* stimulating 
cells (usually BN spleen cells) were treated with 50 pg of mitomycin C in 1 ml 
of complete medium for 45 min and washed twice in BSS and resuspended in 
complete medium. Responding cells were placed in culture with mitomycin C- 
treated stimulating cells in 0.2 ml of medium in microtiter U plates (Cooke Engi- 
neering Co., Alexandria, Va.). Cell concentrations of both stimulating and respond- 
ing cells were varied from 4 X 10G cells/ml to 0.5 X lo6 cells/ml to obtain optimum 
conditions. Culture periods varied from 48 hr to 120 hr. One microcurie of 
3H-thymidine ( [ 3H-TdR] specific activity 6 Ci/mmol ; Schwarz-Mann, Orange- 
burg, N.Y.) was added to each well for the final 16 hr of the incubation period, 
and the cultures were harvested and further processed as previously described (8). 
All cultures were carried out in triplicate. All stanclrad errors were less than 5% 
and are not included in the tables. 
Suppressor cell activity was demonstrated as described previously (13). Briefly, 
various numbers of spleen cells from the populations being tested for suppression 
were added to a fixed concentration (2 X lo6 cells/ml) of responding cells. 
Prior to the assay, the cells being tested for suppressor activity were either treated 
with mitomycin C or x-irradiated with 2500 R. MLC was then done as above. 
In Vitro Gene&on of Cytotoxic Lynzphocytes 
MLC was carried out as described above except that instead of adding “H-TdR 
and harvesting 16 hr later, the cells were gently resuspended in each well with a 
0.1 ml semiautomatic pipette (Schwarz-Mann, Orangeburg, N.Y.) and 2 x lo3 
BN lymphoma [a Kirsten virus-induced lymphoma (18) most generously pro- 
vided by Dr. Frank Fitch, Department of Pathology, University of Chicago, 
Chicago, Ill.] target cells, labeled with %r were added to each well. The plates 
were then incubated on a rocking platform for 4 hr at 37°C in a 5% COZ humidified 
atmosphere and then centrifuged at SOOg for 10 min. One-tenth milliliter of the 
supernatant was then carefully withdrawn from each microwell and counted for 
10 min in a Searle gamma counter. Microwells with 0.2 ml of distilled water to 
which labeled target cells were added sen-ed as controls for total releasable 5’Cr. 
Supernatants drawn from wells containing distilled water after the 4-hr incubation 
period contained 80-90s of the total “CT incorporated into the target cells. Baseline 
release was measured from microwells containing either labeled target cells alone 
or mitomycin C-treated stimulating cells and target cells. Values obtained with 
either method were always within 1.0% of each other and were consistently between 
5 and 10% of the distilled water controls. 
Percent cytotoxicity was calculated as follows : 
% cytotoxicity = 
cpm in sup of test group - cpm in sup of baseline control 
cpm in sup of distilled water control - cpm of background 
x 100. 
RESULTS 
Comparison of MLC Reactivity of Various Lymplzoid Popdations 
To ensure optimal conditions when comparing various lymphoid populations for 
iJILC reactivity, various concentrations of both stimulating and responding cells, 
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from 5 x lo5 to 4 x lo6 cells per ml, were mixed. BN stimulating cells were 
blocked with mitomycin C and never incorporated 3H-TdR greater than background 
levels when cultured alone. \il’/Fu responding cells incorporated similar amounts 
of 3H-TdR whether cultured alone or with various concentrations of syngeneic 
cells treated with mitomycin C. In most experiments the responding cells were 
cultured alone as controls. Figure 1 shows the results of an experiment comparing 
MLC reactivity of lymph node cells (LNC), peripheral blood lymphocytes (PBL), 
and spleen cells to BN alloantigens. A responding cell concentration of 2 X lo6 
per ml was optimal to demonstrate a proliferative response although a broad dose 
response relationship was seen when the responding cell concentrations were 
varied. Stimulating cells also produced strong proliferative responses over a broad 
range of concentrations. For subsequent experiments, 5 x lo5 cells per ml was 
used as the stimulating cell concentration because that concentration consistently 
elicited the best proliferative response. Figure 1 also shows the kinetics of the 
reactivity of the various populations. Peak reactivity of the PBL was seen at 
about Day 4. This was variable, however, with similar levels of reactivity frequently 
being demonstrated both on Days 4 and 5. LNC reactivity was frequently demon- 
strable by Day 3 but usually peaked on Day 4 and dropped off sharply by Day 5. 
The responses of the spleen cells, on the other hand, usually peaked on Day 3, if 
any significant reactivity could be seen at all (Fig. lc and d). The responses shown 
in Figure la, lb, and lc are from one experiment using the same pool of BN 
stimulating cells. Figure Id is included as a separate kinetic study of the MLC 
reactivity of rat spleens, again showing low MLC reactivity of the spleen cells. 
These data indicate that although W/Fu rats responded well to RN alloantigen, 
as demonstrated by the MLC responses of LNC and PBL, spleen cells responded 
poorly or not at all. 
MLC Reactivity of Nor~nul Spleen Cells after Depletion of Various Populations 
Using the conditions found to be optimal for MLC reactivity, responding spleen 
cells were depleted of adherent or phagocytic cells and then tested for their ability 
0 t 2 3 4 5 012345 
FIG. 1. Kinetic study of MLC reactivity in various lymphoid populations. (a) PBL, (b) 
LNC, (c) spleen cells, (d) spleen cells. 0 = cpm of responding cells alone (2 X 10” cells/ml). 
0 = cpm in MLC with 0.5 X 10” cells/ml as BN stimulating cell concentration. q = cpm 
in MLC with 1 X 10’ cells/ml as BN stimulating cell concentration. 
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FIG. 2. Comparison of MLC reactivity before and after depletion of adherent (column pass- 
age) or phagocytic (treated with iron and magnet) cells. Open bars represent cpm of effector 
cells incubated alone. Closed bars represent cpm of effector cells stimulated with BN spleen 
cells treated with mitomycin C. 
to respond in the MLC. The results in Figure 2 show the MLC response was 
greatly improved after depletion of adherent or phagocytic cells. The results of 
this experiment indicate that rat spleens contain cells which can respond vigorously 
to BN alloantigens, thus ruling out the possibility that the decreased MLC 
reactivity observed with spleen cells was due to the absence of a highly reactive 
subpopulation of T cells. However, although surface immunofluorescence studies 
have shown the T-cell/B-cell ratio to be relatkely undisturbed after column passage 
or iron treatment, the possibility remained that the enhanced reactivity seen after 
TABLE 1 





Responding cells Third party cells addedb 
Normal spleen Normal spleen + Normal s~ken 
unfractionated 
+ Normal spleen 
column passage column passage 
9.385” 2.277 6,034 2.073 





+ Normal spleen + Sormal spleen 









Normal spleen Normal spleen 









+ Thymus f Normal spleen 
ATS and C 
Media 4,835 1.626 
BN s&en 33,570 3,754 
= Clnn 3H-TdR. 
b Third party cells were treated with mitomycin C unless otherwise noted and added in concentrations equal to tlkat 
of the column-passaged responding cells. 
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these purification procedures was the result of increasing the percentage of a 
reactive subpopulation of T cells rather than depleting suppressor cells. 
Addition of Variozrs Populations of Cells as Third Parties to the MLC 
If normal spleen cells contained suppressor cells, addition of unfractionated cells 
as third parties to MLC with column-purified responder spleen cells should sup- 
press the reactivity. To test this possibility, unfractionated spleen cells were treated 
with mitomycin C or with 2500 R x-irradiation to prevent a proliferative response 
and added as third parties into the MLC in concentrations equal to the responding 
cells. Table 1 shows the results of three representative experiments. In each experi- 
ment, the MLC reactivity of the unfractionated population was compared to that 
of the column-passaged population. In addition, some of the third party cells were 
pretreated to deplete various subpopulations. In experiment 1, addition of unfrac- 
tionated spleen cells greatly reduced the MIX of the column-passaged cells. In 
contrast, addition of the same number of column-passaged cells did not significantly 
decrease the MLC of the column-passaged responders. This indicates that adherent 
suppressor cells are present in the spleen. 
Experiment 2 shows that pretreatment of the third party spleen cells with iron 
and magnet to deplete phagocytes was also highly effective in removing suppressor 
cells. In experiment 3, the suppressor cells were shown to be resistant to 2500 R, 
absent from the thymus, and resistant to treatment with ATS plus complement. 
These experiments indicate that the rat spleen has cells capable of inhibiting a pro- 
liferative response to alloantigen and that the cells are resistant to mitomycin C, 
x-irradiation, and treatment with a specific heterologous T-cell serum plus comple- 
ment. In addition, they are adherent and phagocytic and not found in the thymus. 
TABLE 2 




BN spleen (0.5)* 
Experiment 2 
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BN spleen (0.5) 
Experiment 3 
Media 
BN spleen (0.5) 
Experiment 4 
Media 
BN spleen (0.5) 






























o Percent cytotoxicity. 
* Cells/ml X 10W6. 
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TABLE 3 
Comparison of CML Generated with Various Populations of Responding 





BN spleen (0.5)* 
Experiment 2 
Media 
RN spleen (0.5) 
BN spleen (1) 
Experiment 3 
Media 
BN spleen (0.5) 
BN spleen (1) 
Experiment 4 
Media 
BN spleen (0.5) 
Responding populations 
[Infractionated Spleen after Spleen after 










lymph node cells 
Lymph node cells 




a Percent cytotoxicity. 
* Cells/ml X 10m6. 
In Vitro Generation of Cytotoxic Effector Cells to Alloantigen Using Rat Splee?z 
Cells as Responders 
The ability of spleen cells to become cytotoxic after MLC was also examined. 
Pilot kinetic experiments with unfractionated spleen cells showed the highest cyto- 
toxicity was on the fourth day of culture. Various stimulator/responder cell ratios 
were tested and the concentrations which were best for the proliferative response 
were most consistently optimal for the development of cytotoxic effector cells. 
After 4 days of culture, 2 x 10: viable cells remained in each microwell (about 
50% of the original number). Addition of 2 x 10” labeled target cells, for an 
attacker/target cell ratio of 100 to 1, consistently resulted in the highest percentage 
of target cell lysis. Under these conditions, several experiments were performed to 
more carefully determine the kinetics of the CML of unfractionated spleen cells 
(Table 2). As in the pilot experiments, peak cytotoxicity consistently occurred 
on Day 4. 
Depletion of the Adherelzt and Phagocytic Cells from, the Rrspondkg Cells in the 
CML 
In experiments similar to those described for measuring proliferation, the re- 
sponding spleen cells were placed through a rayon column to remove adherent cells 
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or treated with iron and magnet to remove the phagocytes. Table 3 summarizes the 
results of several experiments. The levels of cytotoxicity generated with unfrac- 
tionated spleen cells varied considerably among experiments, from undetectable 
responses to moderately high levels. In all cases, however, significant increases in 
the cytotoxic responses generated were observed after depletion of adherent 
or phagocytic cells. LNC became highly cytotoxic even without treatment and the 
cytotoxicity was not significantly improved by depletion of phagocytes. 
Addition of Vahous Lywphoid Pojmla~tions to the CML as Third Parties to 
Characterize the Suppressor Cells 
Lymphoid cells from various sources were either x-irradiated or treated with 
mitomycin C to prevent a proliferative response and were added in concentrations 
equal to- that of the responding cells as third parties (Table 4). Experiment 1 shows 
again the enhanced cytotoxic response of cells depleted of adherent cells. This 
TABLE 4 




BN spleen (0.5)b 
Experiment 2 
Media 















Third party cells addedc 











Spleen 2500 R ATS and C 
spleen 
Experiment 3 
Media 2.4 2.3 1.8 0.4 
BN spleen (0.5) 3.3 46.6 10.8 3.3 
Thymus PEC 
Media 2.1 0.8 
BN spleen (0.5) 56.6 1.6 
‘l Percent cytotoxicity. 
* Cells,‘ml x 10-G. 
c Third party cells were treated with mitomyciu C uuleas otherwise rioted arrd ad&d ill COIIC‘CII- 
trations equal to that of the columu-passaged responding cells. 
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TABLE 5 
Addition of Various Concentrations of Third Party Cells into CML Cultures 








BN spleen (0.5) 
Experiment 2 
Media 
BN spleen (0.5) 
Media 
BN spleen (0.5) 
Media 










a Percent cytotoxicity. 
* Cells/ml X 1OV. 
Source of third 
party cells 
Concentration of third party cells X 10-6/ml added 
0 0.12 0.25 0.5 1.0 2.0 4.0 
2.3a 1.4 1.8 1.6 
46.6 28.5 10.8 3.3 
3.4 2.1 3.6 
46.3 56.6 48.2 
1.0 0.9 0.6 0.1 0.8 
9.6 4.9 2.9 1.2 1.6 
-0.2 
46.7 
0.3 -0.2 -0.4 0.2 
34.9 33.7 17.2 0.7 
-0.8 -0.1 0.7 
38.6 37.5 40.7 
-0.7 0.1 -1.5 -0.2 1.0 0.9 
18.7 3.5 8.6 0.9 0.6 1.5 
increased response was largely abrogated by addition of mitomycin C-treated 
unfractionated spleen cells to the cultures. In contrast, pretreatment of the third 
party cells with rayon column passage largely abrogated the suppressive effect. In 
experiment 2, addition of irradiated cells instead of cells treated with mitomycin C 
demonstrated that the suppressive effect is radioresistant. In addition, pretreatment 
of the spleen cells with iron and magnet to deplete the phagocytic cells largely 
abrogated the suppressive effect of the unfractionated population. Experiment 3 
shows that cells treated with ATS plus complement were even more suppressive 
than the unfractionated controls and this has been a consistent finding. Addition 
of thymocytes into the CML cultures frequently stimulated the generation of cyto- 
toxicity as shown in this experiment. In contrast, addition of light mineral oil- 
induced PECs always completely abrogated the cytotoxic response. Table 5 illu- 
strates the relative suppressor activities of unfractionated spleen cells compared 
to thymus and PEC. In these experiments, column-passaged responding spleen 
cells were combined with various concentrations of the third party cells and the 
cytotoxicity generated measured on the fourth day of culture. In both experiments 
a concentration of spleen cells 16 times the concentration of PECs was required 
to give similar amounts of suppression. At no concentration tested did the addition 
of thymocytes suppress the cytotoxic response as much as the smallest dose of 
PECs. 
DISCUSSION 
The results of the present study provide an explanation fur difficulties previously 
observed in generating a proliferative or cytotoxic response to alloantigens in vitro 
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using rat spleens as responding cells (1, 6). We have found that the poor pro- 
liferative and cytotoxic responses observed are due to the activity of suppressor 
cells present normally in rat spleens and not to the lack of cells capable of respond- 
ing. Experiments in which adherent- or phagocytic cells were depleted from the 
responding cells showed greatly augmented MLC and CML activity. This sug- 
gested that the suppressor cells were phagocytic and adherent. This was supported 
by the finding that, although the addition of unfractionated cells into MLCs as 
third parties strongly suppressed both the proliferative and cytotoxic responses, 
spleen cells depleted of adherent or phagocytic cells had no such effect. Pretreat- 
ment of the cells with ATS and C never decreased the suppressor effect and usually 
enriched for it. Thymocytes contained very little if any suppressor activity. In con- 
trast, PECs consistently were very highly suppressive. In addition, the suppressor 
cell did not require proliferation to be effective as demonstrated by all the experi- 
ments in which the third party cells were either treated with mitomycin C or x- 
irradiation. These data indicate the suppressor cells are probably macrophages. 
This is consistent with previous reports from our laboratory. Tumor-bearing mice 
(8) and rats (9) and mice injected with Co~ynebactcvium fml”~mz (19) have been 
shown to have a population of splenic macrophages which can inhibit proliferative 
responses to mitogens and tumor-associated antigens and also the in vitro gener- 
ation of a secondary cytotoxic response to tumor-associated antigens. In addition, 
we have recently shown that normal rat spleens have suppressor macrophages 
which can inhibit secondary proliferative responses to tumor-associated antigens 
(13). Fernbach et al. (12) have shown that macrophages in PECs can inhibit 
MLC and CML in the mouse, The present study extends these observations to 
include the rat. 
Spleen cells are routinely used in in z&o assays of cellular immunity in mice. 
From this study, it is apparent that unfractionated rat spleen cells may give sub- 
optimal responses in in vitro assays. \!‘hether suppressor macrophages are only 
present in normal rat spleens and not in normal mouse spleens, or whether the 
suppressor activity in normal mouse spleens is just too low to be detected in the 
usual in vitro assays is unclear. However, results of the growth inhibition assay 
[which reflects antiproliferative effects of macrophages in mice (14) and rats (13)] 
suggest that suppressor macrophage activity may exist in normal mouse spleens 
also but to a far lesser degree (14). Thus, it is likely that either rat splenic macro- 
phages are more suppressive than mouse splenic macrophages or that rat lympho- 
cytes are more sensitive to the suppressor effects. It is possible that rats are 
naturally exposed to more antigenic stimuli with resulting increased baseline levels 
of macrophage activation, but against this is the finding that germ-free rat spleens 
were just as inhibitory in the GIA as spleen cells of conventionally bred rats 
(Oehler and Herberman, unpublished observations). 
Folch and Waksman (7) have previously described suppressor cell activity in 
the spleens of normal rats, which could inhibit MLC responses. They characterized 
the suppressor cell as adherent and sensitive to pretreatment with cycloheximide 
and resistant to pretreatment with mitomycin C. However, since they have found 
suppressor cell activity to be largely abrogated by adult thymectomy, irradiation, 
and bone marrow reconstitution, they have concluded that it is a T cell. 
Our data would support the characteristics they described for the suppressor 
cell, i.e., that it is adherent and does not require proliferation to be effective. The 
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main difference in our conclusions stems from the interpretation of the in ViVO 
aspect of their studies, which indicated that R rats have little or no suppressor 
activity. A reasonable explanation for the disparate findings would be that rat 
splenic macrophages may require a certain level of T-cell activity in zdvo in order 
to acquire or maintain their suppressor activity. In rats without ilz viva T-cell 
influence, splenic macrophages may become less activated or may migrate from 
the spleen. There is abundant evidence that, for some functions, T cells are required 
for activation of macrophages (20-22). 11-e are currently performing experiments 
to directly determine whether the acti\.ation of splenic suppressor macrophages is 
T cell dependent. 
Of central importance is the in z&o significance of these findings. In the past 
few years, much attention has been directed toward regulation of the immutie 
response and numerous reports have implicated T cells as the primary regulatory 
cell. Depending on the conditions present, T cells have been shown to either help 
or suppress B-cell responses to antigen (23). Similarly, T cells have been reported 
to suppress or enhance the responses of other T cells (3, 23-29). The present study 
shows that macrophage type non-T cells found in normal rat spleens can suppress 
T-cell responses and therefore may also be involved in the regulation of the immune 
response. In addition, it is possible that in some studies in which suppressor T 
cells have been described, as in the suppressor phenomenon reported by Folch and 
Waltsman (/‘), the suppressor cells may in fact be T cell-dependent suppressor 
macrophages. 
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